Background: Biomarkers, such as microRNAs, are helpful in diagnosing colorectal cancer, regulating disease progression, predicting disease recurrence, and determining therapy success. This research aimed to look at the clinicopathological characteristics of serum miRNA-203a-3p expression in colorectal cancer patients.
Methods And Results: This case-control study was conducted on 43 patients with colorectal cancer and 43 healthy individuals.
Aim: Biochemical markers, including microRNAs (miRs), may facilitate the diagnosis and prognosis of breast cancer. This study was aimed at assessing serum miR-155 expression in patients with breast cancer and receptors.
Methods: This case-control study was conducted on 36 patients with breast cancer and 36 healthy individuals.